ALKERAN 2mg film-coated tablets medication leaflet

L01AA03 melphalan • Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues

Melphalan is a chemotherapy agent primarily used to treat certain types of cancer, such as multiple myeloma and ovarian cancer. It works by interfering with the DNA of cancer cells, preventing them from dividing and spreading.

Melphalan is administered either orally or intravenously, depending on the type and stage of cancer being treated. The treatment may be associated with side effects such as nausea, vomiting, decreased blood cell counts, and an increased risk of infections.

Patients undergoing melphalan treatment must be closely monitored by their doctor to assess effectiveness and manage any adverse reactions. It is important to strictly follow the prescribed doses.

This medication is used only under strict medical supervision and is not recommended for pregnant or breastfeeding women due to risks to the fetus or child.

General data about ALKERAN 2mg

Substance: melphalan

Date of last drug list: 10-04-2026

Commercial code: W58865001

Concentration: 2mg

Pharmaceutical form: film-coated tablets

Quantity: 25

Product type: original

Price: 105.38 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: EXCELLA GMBH - GERMANIA

Holder: ASPEN PHARMA TRADING LIMITED - IRLANDA

Number: 11742/2019/01

Shelf life: 2 years

Concentrations available for melphalan

200mg, 2mg, 50mg

Compensation lists for ALKERAN 2mg ASPEN

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

105.38 RON

105.38 RON

0.00 RON

NHP 9.1 (C2) - Spinal cord transplant

Price

Copayment

Patient

105.38 RON

105.38 RON

0.00 RON